DFT calculations at the BP86/TZ2P level were carried out to analyze quantitatively the metal-ligand bonding in transition-metal complexes that contain imidazole (IMID), imidazol-2-ylidene (nNHC), or imidazol-4-ylidene (aNHC). The calculated complexes are [Cl4TM(L)] (TM = Ti, Zr, Hf), [(CO)5TM(L)] (TM = Cr, Mo, W), [(CO)4TM(L)] (TM = Fe, Ru, Os), and [ClTM(L)] (TM = Cu, Ag, Au). The relative energies of the free ligands increase in the order IMID < nNHC < aNHC. The energy levels of the carbon sigma lone-pair orbitals suggest the trend aNHC > nNHC > IMID for the donor strength, which is in agreement with the progression of the metal-ligand bond-dissociation energy (BDE) for the three ligands for all metals of Groups 4, 6, 8, and 10. The electrostatic attraction can also be decisive in determining trends in ligand-metal bond strength. The comparison of the results of energy decomposition analysis for the Group 6 complexes [(CO)5TM(L)] (L = nNHC, aNHC, IMID) with phosphine complexes (L = PMe3 and PCl3) shows that the phosphine ligands are weaker sigma donors and better pi acceptors than the NHC tautomers nNHC, aNHC, and IMID.
No takes yet. Share an insight, caveat, or question.
Tonner et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: